Eli Lilly’s rheumatoid arthritis medication Olumiant (baricitinib) may be the next treatment for COVID-19, thanks to AI analysis
Eli Lilly’s rheumatoid arthritis medication, Olumiant (baricitinib), is currently in phase 3 clinical trials to become a potential drug used […]